Cyclo Therapeutics : Submission of Nda to FDA & Marketing Authorization Application to European Medicines Agency Is Targeted for 2H 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.